Our Focus:
Investing in Safe AI and Biotech for People.
WHY AiRock Equity Fund I
Safe AI and Biotech Strategy: AI-enabled healthcare. AI Containment. AI business. With our Human+AI fund manager, we project an 80% success rate for competitive investment performance and extreme social impact for people and humanity.
Scientific consensus: Artificial General Intelligence (AGI) must be contained and provably safe for beneficial outcomes for people, forever.
The Age of AI and Biotech has begun
Artificial Intelligence (AI) is now the most important technology development since the Gutenberg Printing Press (1445)
The Gutenberg Press enabled the information and scientific revolution with cost-effective recording and transfer of knowledge, on paper. AI creates knowledge.
AI enables automation of intellectual work at unlimited digital scale. The potential benefits of AI to people and humanity are absolutely transformative.
However, if not Contained forever, AI could lead to the extinction of humanity.
WHAT is our AiRock Opportunity
AI can now perform many tasks at expert human level. AI-enabled Healthcare businesses will be competitive and prosperous in biomedical service markets.
“Sizing the prize” (2023) predicts a $15.7 trillion AI industry. (report by PwC)
HOW we invest in AI-enabled Healthcare and Safe AI
Strategy-1.
Investing in safe AI-enabled healthcare companies, and AI Containment. Picked by our expert management team, for competitive performance.
Strategy-2.
Investing in safe AI with Human+AI Intelligence. Expert knowledge combined with AI predictive analytics, for competitive performance.
AiRock invests only in provably safe AI-enabled business and biotech. AiRock is a unique investment opportunity for competitive financial performance, with extremely important impact for people.
FITZGERALD: The rich are different from us. HEMMINGWAY: Yes, they have more money. — “The Lost Generation” (1925)
IMPORTANT DISCLAIMER. Not an offer to invest. Professional investors only. Investors may lose all or part of their investment. See prospectus for terms and conditions.